🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Nanoparticle albumin-bound paclitaxel

Found 204 matching trials

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...

Status

Unknown

Location

Memorial Sloan-Kettering Cancer Center

Start Date

2006-07

Trial ID

NCT00436709

Treatments Being Tested

bevacizumab pegfilgrastim cyclophosphamide doxorubicin hydrochloride paclitaxel albumin-stabilized nanoparticle formulation flow cytometry immunoenzyme technique immunologic technique laboratory biomarker analysis adjuvant therapy immunoscintigraphy

Study of Paclitaxel in Patients With Ovarian Cancer

PHASE3

RATIONALE: Paclitaxel is one of the most widely used human anticancer agent...

Status

Completed

Location

Gomel Regional Clincial Oncology Center

Start Date

2009-02

Trial ID

NCT00989131

Treatments Being Tested

Paclical®Taxol®

DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer

PHASE1

This clinical trial tests how well dynamic contrast enhanced magnetic reson...

Status

Not Yet Recruiting

Location

Ohio State University Comprehensive Cancer Center

Start Date

2026-09-01

Trial ID

NCT07705919

Treatments Being Tested

Biospecimen Collection Computed Tomography Dynamic Contrast-Enhanced Magnetic Resonance Imaging Fluorouracil Gadolinium-Chelate Gemcitabine Irinotecan Leucovorin Calcium Nab-paclitaxel Oxaliplatin Point-of-care portable perfusion phantom (P4)

Study of Topical SOR007 Ointment for Cutaneous Metastases

PHASE1

This study evaluates a topical nanoparticle paclitaxel ointment (SOR007) fo...

Status

Completed

Location

University of Southern California

Start Date

2018-01-31

Trial ID

NCT03101358

Treatments Being Tested

SOR007 (Uncoated Nanoparticle Paclitaxel) Ointment

A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery

PHASE1

This is a Phase I, single-arm, open-label, prospective, non-randomized, sin...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2026-07-31

Trial ID

NCT07724106

Treatments Being Tested

Low Dose middle dose high dose

Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer

PHASE1

RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilize...

Status

Completed

Location

Baylor Research Institute

Start Date

2009-03-01

Trial ID

NCT00851877

Treatments Being Tested

Cetuximab Cisplatin Nab-Paclitaxel intensity-modulated radiation therapy

Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

PHASE2

This phase II trial studies how well nab-paclitaxel and gemcitabine hydroch...

Status

Completed

Location

OHSU Knight Cancer Institute

Start Date

2016-01-21

Trial ID

NCT02427841

Treatments Being Tested

Fluorouracil Gemcitabine Image Guided Radiation Therapy Intensity-Modulated Radiation Therapy Laboratory Biomarker Analysis Nab-paclitaxel Therapeutic Conventional Surgery

Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis

N/A

Taxane-based agents are widely used in the treatment of esophageal squamous...

Status

Completed

Location

West China Hospital

Start Date

2026-04-01

Trial ID

NCT07549269

Treatments Being Tested

The cohort included 161 patients treated with solvent-based paclitaxel and 226 treated with nanoparticle albumin-bound paclitaxel.

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

PHASE2

This randomized phase II trial studies how well high or standard intensity ...

Status

Terminated

Location

Kaiser Permanente Oakland-Broadway

Start Date

2013-08

Trial ID

NCT01921751

Treatments Being Tested

low intensity radiation therapy Capecitabine Gemcitabine high intensity radiation therapy nab-Paclitaxel

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

PHASE2

RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilize...

Status

Withdrawn

Location

Multiple Locations

Start Date

2008-08

Trial ID

NCT00748163

Treatments Being Tested

paclitaxel albumin-stabilized nanoparticle formulation sunitinib malate

Previous Next